Invesaro

Stocks Consumer discretionary PASW

NASDAQ · Consumer discretionary

Ping An Biomedical Co., Ltd. (PASW)

Ping An Biomedical Co., Ltd. reported revenue of $4.8M in fiscal 2025. It posted a net loss of $1.8M. At September 30, 2025 it held $164.7K in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on January 30, 2026.

Price
$0.13
-1.93% on the day · September 25, 2026
52-week range $0.11 to $1.32
Market cap
$15.8M
Revenue (FY2025)
$4.8M
Net margin
-37.6%

What Ping An Biomedical Co., Ltd. does

Ping An Biomedical Co., Ltd. is registered with the SEC under industry code SIC 2300 (Apparel & Other Finishd Prods of Fabrics & Similar Matl). Its shares trade on NASDAQ under the ticker PASW.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$4.8M-$2.1M-$1.8M-$0.10n/a

Full financial statements: income, balance sheet and cash flow

Where PASW ranks in Consumer discretionary

Revenue$4.8M
#903 of 955 in Consumer discretionary · Bottom 5%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer discretionary

Latest SEC filings

What Ping An Biomedical Co., Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 11, 2026
    Foreign issuer update 6-K
  2. August 7, 2026
    Foreign issuer update 6-K
  3. July 22, 2026
    Foreign issuer update 6-K
  4. July 20, 2026
    Foreign issuer update 6-K
  5. May 27, 2026
    Foreign issuer update 6-K
  6. March 19, 2026
    Foreign issuer update 6-K
  7. March 9, 2026
    Foreign issuer update 6-K
  8. February 13, 2026
    IPO registration (foreign issuer) F-1
  9. February 12, 2026
    Foreign issuer update 6-K
  10. January 30, 2026
    Annual report (foreign issuer) 20-F · period to September 30, 2025Revenue was $4.8M; diluted EPS was -$0.10.

Recent insider filings (Forms 3, 4 and 144): 5, the latest on April 8, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about PASW

What does Ping An Biomedical Co., Ltd. do?

Ping An Biomedical Co., Ltd. is registered with the SEC under industry code SIC 2300 (Apparel & Other Finishd Prods of Fabrics & Similar Matl). Its shares trade on NASDAQ under the ticker PASW.

Is Ping An Biomedical Co., Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $1.8M on revenue of $4.8M.

How much revenue does Ping An Biomedical Co., Ltd. make?

In fiscal 2025 Ping An Biomedical Co., Ltd. reported revenue of $4.8M.

When did Ping An Biomedical Co., Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on January 30, 2026. It covers the period to September 30, 2025. Its newest filing of any kind is the foreign issuer update from September 11, 2026.

Similar companies

LULU
lululemon athletica inc.
AS
Amer Sports, Inc.
LEVI
Levi Strauss & Co
UAA
Under Armour, Inc.
GIL
Gildan Activewear Inc.
COLM
Columbia Sportswear Co

Compare PASW with

Compare PASW with any company

Follow PASW

Get an email when Ping An Biomedical Co., Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PASW: get an email when it files

Where the numbers come from

Financial figures are the values Ping An Biomedical Co., Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.